333 related articles for article (PubMed ID: 15799121)
21. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
22. Turkish version of the Johns Hopkins Restless Legs Syndrome Quality of Life Questionnaire (RLS-QoL): validity and reliability study.
Güler S; Nesrin Turan F
Qual Life Res; 2015 Nov; 24(11):2789-94. PubMed ID: 25999305
[TBL] [Abstract][Full Text] [Related]
23. Restless legs syndrome severity associated with reduced physical function in adults with multiple sclerosis.
Cederberg KLJ; Schuetz ML; Mathison B; Motl RW
Gait Posture; 2022 Sep; 97():56-61. PubMed ID: 35882097
[TBL] [Abstract][Full Text] [Related]
24. Relationship between Restless legs syndrome associated symptoms and presence of depression during pregnancy.
Sawatari H; Yoshimura C; Amagase H; Takewaka M; Nakashima K; Imaoka C; Obama H; Miyanaga N; Ando SI
Women Health; 2022 Mar; 62(3):265-271. PubMed ID: 35354362
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
Allen RP; Ritchie SY
Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
[TBL] [Abstract][Full Text] [Related]
26. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population.
Abetz L; Arbuckle R; Allen RP; Mavraki E; Kirsch J
Health Qual Life Outcomes; 2005 Dec; 3():79. PubMed ID: 16329756
[TBL] [Abstract][Full Text] [Related]
27. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS.
Rajaram SS; Shanahan J; Ash C; Walters AS; Weisfogel G
Sleep Med; 2005 Mar; 6(2):101-6. PubMed ID: 15716213
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
Giorgi L; Ritchie SY; Kirsch JM
Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
[TBL] [Abstract][Full Text] [Related]
30. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
Benes H; Kohnen R
Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive Vagus Nerve Stimulation: A New Therapeutic Approach for Pharmacoresistant Restless Legs Syndrome.
Hartley S; Bao G; Zagdoun M; Chevallier S; Lofaso F; Leotard A; Azabou E
Neuromodulation; 2023 Apr; 26(3):629-637. PubMed ID: 36400697
[TBL] [Abstract][Full Text] [Related]
32. High false-positive rate of questionnaire-based restless legs syndrome diagnosis in multiple sclerosis.
Mery V; Kimoff RJ; Suarez I; Benedetti A; Kaminska M; Robinson A; Lapierre Y; Bar-Or A; Trojan DA
Sleep Med; 2015 Jul; 16(7):877-82. PubMed ID: 25912601
[TBL] [Abstract][Full Text] [Related]
33. Frequency, severity and risk factors for restless legs syndrome in healthcare personnel.
Civi S; Kutlu R; Tokgoz S
Neurosciences (Riyadh); 2012 Jul; 17(3):230-5. PubMed ID: 22772928
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
[TBL] [Abstract][Full Text] [Related]
35. Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
Cederberg KLJ; Jeng B; Sasaki JE; Braley TJ; Walters AS; Motl RW
J Neurol Sci; 2019 Dec; 407():116531. PubMed ID: 31654833
[TBL] [Abstract][Full Text] [Related]
36. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
Klepitskaya O; Liu Y; Sharma S; Sillau SH; Tsai J; Walters AS
Neurology; 2018 Sep; 91(11):e1013-e1021. PubMed ID: 30111549
[TBL] [Abstract][Full Text] [Related]
37. Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials.
Canafax DM; Bhanegaonkar A; Bharmal M; Calloway M
BMC Neurol; 2011 Apr; 11():48. PubMed ID: 21527006
[TBL] [Abstract][Full Text] [Related]
38. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
[TBL] [Abstract][Full Text] [Related]
39. Restless Legs Syndrome in Adults in Peking Union Medical College Hospital.
Chen JH; Huang R; Luo JM; Xiao Y; Zhong X; Liu XQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):548-553. PubMed ID: 27825412
[TBL] [Abstract][Full Text] [Related]
40. Restless legs syndrome and near-infrared light: An alternative treatment option.
Mitchell UH; Myrer JW; Johnson AW; Hilton SC
Physiother Theory Pract; 2011 Jul; 27(5):345-51. PubMed ID: 20977377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
